WHTCF (WELL Health Technologies) EBITDA per Share: $0.59 (TTM As of Mar. 2026)


WHTCF WELL Health Technologies Corp WHTCF
76 GF Score
Price $2.91
GF Value $5.12
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is WELL Health Technologies EBITDA per Share?

WELL Health Technologies WHTCF -0.02% 76 EBITDA per Share is $0.59 as of Mar. 2026. GuruFocus rates WHTCF with a GF Score™ of 76/100 and a GF Value™ of $5.12 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 532 Healthcare Providers & Services companies, WELL Health Technologies ranks better than 52.44% on this metric.

WELL Health Technologies's EBITDA per Share for the three months ended in Mar. 2026 was $0.11. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.59.

During the past 12 months, the average EBITDA per Share Growth Rate of WELL Health Technologies was 211.20% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for WELL Health Technologies's EBITDA per Share or its related term are showing as below:

WHTCF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -75.4   Med: 3.3   Max: 59
Current: 11.6

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of WELL Health Technologies was 59.00% per year. The lowest was -75.40% per year. And the median was 3.30% per year.

WHTCF's 3-Year EBITDA Growth Rate is ranked better than
52.44% of 532 companies
in the Healthcare Providers & Services industry
Industry Median: 10.2 vs WHTCF: 11.60

WELL Health Technologies's EBITDA for the three months ended in Mar. 2026 was $28 Mil.

During the past 12 months, the average EBITDA Growth Rate of WELL Health Technologies was 203.30% per year. During the past 3 years, the average EBITDA Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of WELL Health Technologies was 74.90% per year. The lowest was -160.80% per year. And the median was -54.40% per year.


WELL Health Technologies  (OTCPK:WHTCF) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


WELL Health Technologies EBITDA per Share Related Terms


WELL Health Technologies EBITDA per Share Historical Data

* Premium members only.

The historical data trend for WELL Health Technologies's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WELL Health Technologies EBITDA per Share Chart

WELL Health Technologies Annual Data
Trend Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.33 0.36 0.32 0.45

WELL Health Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.17 0.14 0.16 0.11
WHTCF
76GF Score
WELL Health Technologies Corp WHTCF
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WELL Health Technologies EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

WELL Health Technologies's EBITDA per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA per Share(A: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=112.757/252.801
=0.45

WELL Health Technologies's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=27.98/254.874
=0.11

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $0.59 mean?
WELL Health Technologies (WHTCF) has a EBITDA per Share of $0.59 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on WELL Health Technologies and its competitors. According to the industry distribution chart, WELL Health Technologies ranks #253 out of 532 companies in the Healthcare Providers & Services industry, placing it in the top 47.6%.
Is WELL Health Technologies' EBITDA per Share too high?
WELL Health Technologies' current EBITDA per Share is $0.59. The Healthcare Providers & Services industry median EBITDA per Share is 10.20. WELL Health Technologies' value of $0.59 is 94.2% below this industry median. Based on the distribution chart, WELL Health Technologies ranks #253 out of 532 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' EBITDA per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, WELL Health Technologies ranks #253 out of 532 companies for EBITDA per Share. This puts WELL Health Technologies in the upper half of its industry. The industry median EBITDA per Share is 10.20. WELL Health Technologies' value of $0.59 is 94.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Healthcare Providers & Services company?
The median EBITDA per Share among Healthcare Providers & Services companies is 10.20, based on 532 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current EBITDA per Share of $0.59 is 94.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on WELL Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median EBITDA per Share is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current EBITDA per Share is $0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.12, compared to a current price of $2.91 — trading 43.2% below its estimated fair value. The current EBITDA per Share is $0.59 and 94.2% below the Healthcare Providers & Services industry median of 10.20. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current EBITDA per Share is $0.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WELL Health Technologies (WHTCF) Overvalued in 2026?

Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued. The current stock price of $2.91 is trading 43.2% below its estimated GF Value™ of $5.12. GuruFocus considers WELL Health Technologies to be Possible Value Trap.

Key valuation signals for WHTCF:

  • EBITDA per Share: $0.59
  • GF Value™: $5.12 vs. price of $2.91 (43.2% below fair value)
  • GF Score™: 76/100 with 6 warning signs
  • Industry Position: 94.2% below the Healthcare Providers & Services median (#253 of 532)

No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WELL Health Technologies Business Description

Other Exchanges W7V:GermanyWELL:Canada
Address 375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score

Get the complete analysis for WHTCF

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price
$5.12
GF Value